SESSION 74 SCHEDULE
Friday
SESSION 74: NEW OR IMPROVED TECHNIQUES OR TECHNOLOGIES; SOME HOT CAROTID AND VERTEBRAL TOPICS
x
6:45 AM - 6:50 AM Cognitive And MRI Changes After Proximal TEVAR And TAVR Show The Need For Cerebral Protection During These Procedures: What Devices Are Available
  Presenter(s):Ian Loftus, MD  
  View Abstract      
6:51 AM - 6:56 AM Use Of The VORTEC Technique: Another Method To Facilitate Hypogastric Revascularization During EVAR
  Presenter(s):Zoran Rancic, MD, PhD  
  View Abstract      
6:57 AM - 7:02 AM How To Make CEA Safer And Better In 2014
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Abstract      
7:03 AM - 7:08 AM Optimal Evaluation And Surgical Approaches To Carotid Body Tumors In 2014
  Presenter(s):John (Jeb) W. Hallett, MD  
  View Abstract      
7:09 AM - 7:14 AM What Is New In The Treatment Of Vertebro-Basilar Disease
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
7:15 AM - 7:20 AM More Common Finding Of Thrombus Overlying A Carotid Plaque During CEA: What Is Its Significance Or Is It Related To The Earlier Performance Of CEA Currently Being Done In Symptomatic Patients
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) / Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS  
  View Abstract      
7:21 AM - 7:26 AM Association Between Carotid Plaque Type And Internal Carotid Artery Occlusion: Therapeutic Implications
  Presenter(s):Christos D. Liapis, MD  
  View Abstract      
7:27 AM - 7:32 AM How Can MRI Help To Select The Best And Personalized Treatment For A Given Carotid Patient: Can It Measure Plaque Size And Activity Accurately
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Abstract      
7:33 AM - 7:38 AM What Can Duplex Ultrasonography Tell Us About Carotid Plaque Area And Juxtaluminal Black Area (JBA): How Do These Correlate With Stroke Risk And Do These Parameters And Stroke Risk Change With Statin Therapy
  Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD  
  View Abstract      
7:39 AM - 7:44 AM How Do Ultrasound And Microbubbles Help With Carotid Plaque Evaluation And Selection Of Asymptomatic Patients For CEA Or CAS
  Presenter(s):Chung S. Lim, MBBS, MRCS, PhD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
7:45 AM - 7:52 AM Panel Discussion
END OF SESSION 74
 
SESSION 75 SCHEDULE
Friday
SESSION 75: MORE ABOUT THORACIC AND ABDOMINAL AORTIC DISEASE AND AORTIC DISSECTIONS; LARGE SHEATH ENDOVASCULAR ACCESS
x
7:52 AM - 7:57 AM Alseal HQS Sheath To Minimize Blood Loss With Large Diameter Endovascular Devices
  Presenter(s):Claude Mialhe, MD  
  View Abstract      
7:58 AM - 8:03 AM DEBATE: Large Sheath Suture Closure Devices: Why Proglide Is Better: Tips And Tricks
  Presenter(s):Carlos H. Timaran, MD  
  View Abstract      
8:04 AM - 8:09 AM DEBATE: Large Sheath Suture Closure Devices: Why Prostar Is Better: Tips And Tricks
  Presenter(s):Ian Loftus, MD  
  View Abstract      
8:10 AM - 8:15 AM Which Patients Should Not Be Treated By TEVAR For Aneurysms Or TBADs Because Their 3-Year Mortality Or Reintervention Rates Are So High
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
8:16 AM - 8:21 AM Outcomes Of TEVAR For Complicated Acute TBADs Are Favorable: 1-Year Results From The US VALIANT (Medtronic) IDE Trial
  Presenter(s):Rodney A. White, MD / Joseph E. Bavaria, MD  
  View Abstract      
8:22 AM - 8:27 AM Multicenter 1-Year Favorable IDE Trial Results Of Conformable Gore C-TAG Device In TEVAR For Acute Complicated TBADs
  Presenter(s):Richard P. Cambria, MD  
  View Abstract      
8:28 AM - 8:33 AM Importance Of Biomechanical Factors For Ascending Aortic Endografts: What Can Be Done To Overcome These Factors
  Presenter(s):Rachel E. Clough, MD, PhD / Peter R. Taylor, MA, MChir, FRCS, ARCM  
  View Abstract      
8:34 AM - 8:39 AM Cerebral Embolic Injury Silent And Symptomatic During TEVAR: Incidence And Risk Factors: Significance Of Silent MRI Defects: What Can Be Done To Protect Against These Injuries
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Abstract      
8:40 AM - 8:45 AM Potential For Treating Type A Dissections With A Combined Transcatheter Aortic Valve Replacement And Ascending Aortic Stent-Graft: What Will And Will Not Be Possible
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Abstract      
8:46 AM - 8:53 AM Panel Discussion
END OF SESSION 75
 
SESSION 76 SCHEDULE
Friday
SESSION 76: IN HONOR OF DAVID E. SUMNER, MD: CAROTID ARTERY AND SUPRA-AORTIC BRANCH TOPICS
x
8:53 AM - 8:58 AM How To Pick The Best Stent For CAS: It Is A Patient-Anatomy And Lesion Specific-Choice
  Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD  
  View Abstract      
8:59 AM - 9:04 AM How To Improve CAS Results With Better Approaches For Access, Mesh/Membrane Covered Stents (Roadsaver, C-Guard, Scaffold) And Better Embolic Protection: What Is The Evidence
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
  View Abstract      
9:05 AM - 9:10 AM Will Robotic Assistance With The Magellan Robotic System Help To Navigate The Arch And Its Branches For CAS Less Traumatically
  Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD  
  View Abstract      
9:11 AM - 9:16 AM DEBATE: For Patients Who Are Undergoing CABG And Who Require Carotid Treatment CAS Is The Way To Go: Many Patients Need CAS
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Abstract      
9:17 AM - 9:22 AM DEBATE: Very Few Patients Need CAS Or CEA With Any Coronary Bypass Procedures
  Presenter(s):Ross Naylor, MD, FRCS  
  View Abstract      
9:23 AM - 9:28 AM Outcomes Of CAS For Radiation Induced Carotid Stenosis Are Equal To Those For Typical Arteriosclerotic Carotid Stenosis – Despite Increased Tortuosity Of Carotid Arteries: What Precautions Need To Be Taken
  Presenter(s):Peter L. Faries, MD, FACS  
  View Abstract      
9:29 AM - 9:34 AM Behavior Of Extracranial Carotid Aneurysms: How Should They Best Be Treated: Data From An International Registry
  Presenter(s):Gerrit J. de Borst, MD  
  View Abstract      
9:35 AM - 9:40 AM Improved Treatment Of Iatrogenic Catheter Related Brachiocephalic Artery Injuries Using Endovascular Techniques: Tips And Tricks
  Presenter(s):Mark K. Eskandari, MD  
  View Abstract      
9:41 AM - 9:46 AM How Can Biochemical Markers CRP And BNP Be Helpful In Vascular Patient Management: Can CRP Levels Predict Progression Of Carotid Stenosis
  Presenter(s):Patrick A. Stone, MD  
  View Abstract      
9:47 AM - 9:52 AM Diaphragm Of The Cervical Carotid Arteries: An Underdiagnosed Cause Of Cerebral Infarcts: Diagnosis And Treatment
  Presenter(s):Emmanuel M. Houdart, MD  
  View Abstract      
9:53 AM - 10:00 AM Panel Discussion
10:00 AM - 10:10 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 76
 
SESSION 77 SCHEDULE
Friday
SESSION 77: CAS Vs. CEA RELATED TOPICS: THE FUTURE FOR CAS IS BRIGHT
x
10:10 AM - 10:15 AM Despite Various Claims, What Is The Current Truth About The Effects Of CAS And CEA On Cognitive Function: Is There A Difference Between The Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Abstract      
10:16 AM - 10:21 AM Carotid Procedures (CEA Or CAS) For Acute Stroke: When Should They Be Done And How
  Presenter(s):Laura Capoccia, MD, PhD  
  View Abstract      
10:22 AM - 10:27 AM Outcome Of A High Risk Plaque Study In 6100 Americans: What Does It Tell Us
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Abstract      
10:28 AM - 10:33 AM The Truth About The High Risk Carotid Patient And Which Patients Should Be Enrolled In Future Carotid Trials
  Presenter(s):Gerrit J. de Borst, MD  
  View Abstract      
10:34 AM - 10:39 AM Long-Term Stroke Risk After CEA Has Been Lower Than After CAS: Based On VQI And Medicare US Population-Wide Data
  Presenter(s):Philip P. Goodney, MD, MS  
  View Abstract      
10:40 AM - 10:45 AM DEBATE: CMS (Medicare) Should Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients
  Presenter(s):William A. Gray, MD  
  View Abstract      
10:46 AM - 10:51 AM DEBATE: CMS Should Not Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients
  Presenter(s):Wesley S. Moore, MD  
  View Abstract      
10:52 AM - 10:57 AM Will Recent Improvements In Medical Therapy Lower Stroke Risk In Asymptomatic Carotid Stenosis Patients So Much That Further Treatment Will Be Unnecessary: Are The ACST And ACSRS Studies Now Obsolete And Will They Have To Be Done Again: Is There A High Risk Asymptomatic Patient Group That Will Benefit From CEA Or CAS
  Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD  
  View Abstract      
10:58 AM - 11:05 AM Panel Discussion
THE FUTURE FOR CAS IS BRIGHT
Moderator(s): Thomas G. Brott, MD / Wesley S. Moore, MD  
11:05 AM - 11:10 AM Why CAS Will Have A Renaissance And What Studies Are Needed To Justify It: The Mesh Covered Scaffold Stent (Gore) Should Help
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
11:11 AM - 11:16 AM How To Improve CAS And Prevent Post-Procedural Strokes After CAS: Clinical Experience With The Roadsaver Micromesh Carotid Stent: How Does The Micromesh Stent Compare To Other Mesh-Covered Stents Like The MicroNet (C-Guard) Stent From InspireMD And the Scaffold Stent From Gore
  Presenter(s):Max Amor, MD  
  View Abstract      
11:17 AM - 11:22 AM A New Development In CAS Which Will Improve Results: Is The Cervical Flow Reversal Device (Michi System) From Silk Road The Safest Way To Perform CAS: When Will We Know How Well It Works
  Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD  
  View Abstract      
11:23 AM - 11:28 AM What Is The Pathological And Functional Significance Of Diffusion Weighted MRI (DW MRI) Defects After CEA And CAS: Are They Irrelevant Or A Bad Thing
  Presenter(s):Emmanuel M. Houdart, MD  
  View Abstract      
INTENSIVE MEDICAL THERAPY WITH PROPER STATIN USAGE ETC. IS A DISRUPTIVE INFLUENCE
11:29 AM - 11:34 AM Intensive Medical Therapy With Proper Statin Usage Etc. Is A Disruptive Influence
  Presenter(s):Thomas G. Brott, MD  
  View Abstract      
11:35 AM - 11:40 AM The CREST Trial Did Not Optimize Medical Treatment And Risk Factor Control Especially In the CEA Treated Patients: What Are The Implications
  Presenter(s):Carlos H. Timaran, MD  
  View Abstract      
11:41 AM - 11:46 AM How Will ACST 2, SPACE 2 And CREST 2 Change The CAS vs. CEA Game
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
  View Abstract      
11:47 AM - 11:52 AM What Will The ECST-2 Trial Tell Us About CEA, CAS And Medical Treatment: What Is The Significance Of White Matter And Other MRI Lesions
  Presenter(s):Martin M. Brown, MD  
  View Abstract      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 77
 
SESSION 78 SCHEDULE
Friday
SESSION 78: MORE ABOUT CEA AND CAS
x
1:00 PM - 1:05 PM What Were The Pathophysiological Mechanisms Leading To Intraprocedural Strokes In ICSS
  Presenter(s):Gerrit J. de Borst, MD  
  View Abstract      
1:06 PM - 1:11 PM How To Optimize Outcomes For CAS And CEA By Appropriate Patient Selection And Having Experts In Both Procedures On The Treating Service
  Presenter(s):Carlos Saadeh, MD, FRCSC, FACS  
  View Abstract      
1:12 PM - 1:17 PM Dual Antiplatelet Treatment And Tobacco Use May Increase The Rate Of Progression Of Asymptomatic Carotid Stenosis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Bruce A. Perler, MD, MBA  
  View Abstract      
1:18 PM - 1:23 PM US National Trends In Utilization Of CAS For Carotid Bifurcation Disease: Effect Of CMS (Medicare) Decision And CREST Publications: Where Is CAS Going
  Presenter(s):Mohammad H. Eslami, MD, RVT  
  View Abstract      
1:24 PM - 1:29 PM DEBATE: Treating Recently Symptomatic Carotid Stenosis Patients Rapidly By CEA Trumps All Interventions In Symptomatic Patients: CAS Should Not Be Used In This Setting
  Presenter(s):Ross Naylor, MD, FRCS  
  View Abstract      
1:30 PM - 1:35 PM DEBATE: Not So: Rapid CAS In Recently Symptomatic Carotid Stenosis Patients Can Be Done Safely With Results Equal To CEA
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
  View Abstract      
1:36 PM - 1:41 PM What Is The Long-Term Fate Of The External Carotid Artery After CEA: Why It Matters
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Abstract      
1:42 PM - 1:47 PM Clinical And Imaging Strategies For Predicting Long-Term Stroke Risk In Asymptomatic Patients With Carotid Stenosis
  Presenter(s):Ross Naylor, MD, FRCS  
  View Abstract      
1:48 PM - 1:54 PM Tips And Techniques For Managing Intraprocedural Complications With CAS
  Presenter(s):Claudio J. Schonholz, MD  
  View Abstract      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 78
 
SESSION 79 SCHEDULE
Friday
SESSION 79: LATE BREAKING AND CONTROVERSIAL TOPICS
x
2:00 PM - 2:05 PM Management Of Secondary Hemorrhage From Vein Grafts In Military Extremity Wounds: In A War Setting PTFE Grafts May Be Better Than Vein Grafts
  Presenter(s):Charles J. Fox, MD, FACS  
  View Abstract      
2:06 PM - 2:11 PM Plaque Analysis After Lower Extremity Interventional Treatments And Its Impact On Outcomes
  Presenter(s):Hany Zayed, MD  
  View Abstract      
2:12 PM - 2:17 PM The Metabolic Syndrome And How Does It Lead To Bad Outcomes With Vascular Procedures Like EVAR And CEA
  Presenter(s):Alan Dardik, MD, PhD  
  View Abstract      
2:18 PM - 2:23 PM How Does The Ruby Coil System (From Penumbra) Facilitate Coil Embolization
  Presenter(s):Frank R. Arko, MD  
  View Abstract      
2:24 PM - 2:29 PM Intraluminal PTA Is Better In Diabetics With CLI: Tips To Stay Intraluminal
  Presenter(s):Marco G. Manzi, MD  
  View Abstract      
2:30 PM - 2:35 PM Renal Artery Stenting Is Still A Useful Procedure Despite The CORAL And ASTRAL Trials: When Is This So
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Abstract      
2:36 PM - 2:41 PM Pearls For The Vascular Surgeon/Specialist Managing Patients With Ehlers-Danlos Syndrome
  Presenter(s):James H. Black III, MD  
  View Abstract      
2:42 PM - 2:47 PM How To Treat Super Large AAAs 12-15 cm In Diameter: Is Open Or Endo Better
  Presenter(s):Jacques Busquet, MD  
  View Abstract      
2:48 PM - 2:53 PM Impact Of Selection Bias In RCTs Comparing EVAR To Open Repair For Ruptured AAAs: This Is A Major Flaw In The Recent Trials Including IMPROVE
  Presenter(s):Jonathan R. Boyle, MD, FRCS  
  View Abstract      
2:54 PM - 2:59 PM A Phantom Aorta: Use Of 3D Printer Technology To Facilitate Fenestrated EVAR
  Presenter(s):Benjamin W. Starnes, MD  
  View Abstract      
3:00 PM - 3:10 PM Panel Discussion And Break
Visits Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: MORE LATE BREAKING INFORMATION AND UPDATES
x
3:11 PM - 3:16 PM Endovascular Limb Salvage After Many Failed Open Bypasses And Open Surgical Limb Salvage After Many Failed Endovascular Procedures: Never Give Up
  Presenter(s):Edward Y. Woo, MD  
  View Abstract      
3:17 PM - 3:22 PM Technique For Assessing Lower Extremity (Foot) Perfusion Beyond ABI, PVRs And Toe Pressures
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Abstract      
3:23 PM - 3:28 PM Hybrid Revascularization In CLI Patients: Still An Important And Useful Option: Tips And Tricks
  Presenter(s):Hany Zayed, MD  
  View Abstract      
3:29 PM - 3:34 PM Hybrid Revascularizatons For The “No Option” CLI Patient: What Are They And What Are The Results
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Abstract      
3:35 PM - 3:40 PM Optimal Techniques For Endovascular Management Of AAA Patients With Small Heavily Calcified Distal Aortic Necks And Common Iliac Arteries
  Presenter(s):Ronald M. Fairman, MD  
  View Abstract      
3:41 PM - 3:46 PM Ischemic Colitis After EVAR: What Is The Pathogenesis And Why Is The Incidence Decreasing
  Presenter(s):Benjamin W. Starnes, MD  
  View Abstract      
3:47 PM - 3:52 PM Real Health Consequences To Interventionalists Of Radiation And Wearing Lead: It Is A Big Deal - Largely Unrecognized And What Can Be Done To Lessen These Consequences
  Presenter(s):Lindsay Machan, MD  
  View Abstract      
3:53 PM - 3:58 PM Weightless Lead Protection System For Busy Interventionalists: The Zero Gravity Radiation Protection System From CFI Medical Solutions: Advantages And Limitations
  Presenter(s):Mark A. Farber, MD  
  View Abstract      
3:59 PM - 4:04 PM At What Size Should Degenerative Femoral Aneurysms Be Repaired: Their Natural History Is Now Better Known And This Has Led To Changed Criteria For Repair
  Presenter(s):Peter F. Lawrence, MD  
  View Abstract      
4:05 PM - 4:10 PM Carotid Duplex Studies Can Be Terribly Misleading And Overestimate The Percent Stenosis: What Is The Mechanism: CEA vs. CAS Should Not Be Performed Without A Confirmatory Test
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT  
  View Abstract      
4:11 PM - 4:16 PM Carotid Duplex Studies Can Be Terribly Misleading And Miss Or Underestimate A High-Grade Carotid Stenosis: What Is The Mechanism
  Presenter(s):Glenn M. LaMuraglia, MD  
  View Abstract      
4:17 PM - 4:24 PM Panel Discussion
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: MORE LATE BREAKING INFORMATION AND UPDATES; ADDITIONAL VITAL NEW DATA ON RUPTURED AAAs
x
4:24 PM - 4:29 PM Is There Evidence In 2014 That Inferior Mesenteric Or Lumbar Artery Embolization Before EVAR Is Beneficial And Safe
  Presenter(s):Florian Dick, MD  
  View Abstract      
4:30 PM - 4:35 PM Interobserver Variability In Assigning TASC Or SVS Run-Off Scores: Neither Widely Quoted System Is Worth Much In Real World Usage
  Presenter(s):Steven G. Katz, MD  
  View Abstract      
4:36 PM - 4:41 PM AAA Patients With Highly Angulated Necks Can Be Treated Successfully If Certain Adjunctive Procedures Are Used: Tips And Tricks On How To Use Them
  Presenter(s):Boonprasit Kritpracha, MD  
  View Abstract      
4:42 PM - 4:47 PM Can Endograft Migration After EVAR Be Treated Successfully With Chimney Grafts
  Presenter(s):Ignacio Escotto, MD  
4:48 PM - 4:54 PM Panel Discussion
VITAL NEW DATA ON RUPTURED AAAS AND THEIR TREATMENT
4:54 PM - 4:59 PM How Often After EVAR For Ruptured AAAs Are Type 2 Endoleaks A Problem: How Can They Be Diagnosed And Treated
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Abstract      
5:00 PM - 5:05 PM How Do Type 2 Endoleaks Behave Differently After Elective EVAR And EVAR For Ruptured AAAs: Implications For Treatment
  Presenter(s):Manish Mehta, MD, MPH  
  View Abstract      
5:06 PM - 5:11 PM High Metabolic Activity By PET/CT Correlates With A High Rupture Risk In Patients With A Family History Of AAA: Such Patients Should Have A Lower Diameter Threshold For Repair Than 5.5 cm
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Abstract      
5:12 PM - 5:17 PM Institutional Transfer Of Ruptured AAA Patients Before Definitive Repair And Its Effect On Mortality: Tips And Tricks For Doing It Right
  Presenter(s):Matthew W. Mell, MD, MS / Ronald L. Dalman, MD  
  View Abstract      
5:18 PM - 5:23 PM Technique Of Aortic Balloon Control For Ruptured AAAs: The Technique Is Not Simple
  Presenter(s):Todd Berland, MD / Neal S. Cayne, MD / Frank J. Veith, MD  
  View Abstract      
5:24 PM - 5:29 PM Survival After AAA Rupture X3 In The Same Patient Over Many Years; What Is The Mechanism
  Presenter(s):James May, MD, MS, FRACS, FACS  
  View Abstract      
5:30 PM - 5:35 PM Onyx Can Be Used Successfully To Treat Some Ruptured AAAs, Ruptured Thoracic Aneurysms And Type I Endoleaks: Tips And Tricks In Its Use And When It Will Fail
  Presenter(s):Thomas Larzon, MD, PhD  
  View Abstract      
5:36 PM - 5:45 PM Panel Discussion

End of Program J

END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: ABDOMINAL AORTA AND ILIAC ARTERY RELATED TOPICS
x
6:45 AM - 6:50 AM Spontaneous Aortic Thrombus In The Absence Of Aortic Pathology: What Is Its Embolic Potential And How Should It Be Treated
  Presenter(s):Cynthia K. Shortell, MD  
  View Abstract      
6:51 AM - 6:56 AM Renal Function Decline After EVAR: Is It Important And What Is The Etiology
  Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD  
  View Abstract      
6:57 AM - 7:02 AM CO2 Angiography For EVAR In Patients Intolerant To Contrast: Tips, Tricks And Precautions For Its Use
  Presenter(s):Luigi Inglese, MD  
  View Abstract      
7:03 AM - 7:08 AM DEBATE: Current Stent-Grafts Will Allow Better Outcomes With EVAR Than Those Obtained In The RCTs: EVAR I, DREAM And OVER
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Abstract      
7:09 AM - 7:14 AM DEBATE: Not So: Current Outcomes For EVAR Will Be No Different From Those In The RCTs And The Conclusions Of These Trials Are Valid Today
  Presenter(s):Jan D. Blankensteijn, MD  
  View Abstract      
7:15 AM - 7:20 AM Long-Term Outcomes Of EVAR And Open Repair In A US Medicare Database: How Do These Compare With The RCT (EVAR 1, DREAM And OVER) Outcomes
  Presenter(s):Marc L. Schermerhorn, MD  
  View Abstract      
7:21 AM - 7:26 AM Outcomes And QOL Of EVAR In Octogenarians: The Procedure Is Worthwhile: Based On ENGAGE Registry Results
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Abstract      
7:27 AM - 7:32 AM Internal Iliac Aneurysms: Challenges And Techniques For Open And Endovascular Repair: At What Size (Diameter) Is Repair Indicated
  Presenter(s):Manju Kalra, MBBS  
  View Abstract      
7:33 AM - 7:38 AM DEBATE: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Standard Endografts
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Abstract      
7:39 AM - 7:44 AM DEBATE: Not So: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Fenestrated Endografts
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Abstract      
7:45 AM - 7:53 AM Panel Discussion
END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: MORE ABDOMINAL AORTA RELATED TOPICS
x
7:53 AM - 7:58 AM Finite Element Analysis Is A Tool To Predict AAA Rupture Risk: How Can This Be Determined Easily And How Can It Be Combined With Other Risk Factor Data To Better Predict AAA Rupture Risk: What Is “Equivalent Diameter Rupture Risk” And The Vascops System
  Presenter(s):Dittmar Boeckler, MD / Natzi Sakalihasan, MD, PhD / 
  View Abstract      
7:59 AM - 8:04 AM How To Prevent Gutter Endoleaks With Parallel Grafts
  Presenter(s):Willem Wisselink, MD / Kak Khee Yeung, MD, PhD  
  View Abstract      
8:05 AM - 9:10 AM When Is AAA Repair Justified In Patients With Chronic Renal Insufficiency Or Connective Tissue Disease: By EVAR; By Open Repair
  Presenter(s):Vicente Riambau, MD, PhD  
  View Abstract      
8:11 AM - 8:16 AM Techniques And Strategies For Renal Protection During Open Pararenal And Thoracoabdominal Aneurysm Repair
  Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Abstract      
8:17 AM - 8:22 AM Why Are The Rates Of AAA Sac Regression So High And Of Type 2 Endoleak So Low With The Endologix AFX Grafts: Is It Related To An Extended Proximal Seal Or Other Factors
  Presenter(s):Zachary M. Arthurs, MD  
  View Abstract      
8:23 AM - 8:28 AM Errors In Endograft Sizing And How They Can Influence Outcomes: How To Prevent Them
  Presenter(s):Juan C. Parodi, MD  
  View Abstract      
8:29 AM - 8:34 AM Screening For AAAs Should Be More Selective As AAA Demographics Changes And Incidence Decreases
  Presenter(s):Ian Loftus, MD  
  View Abstract      
8:35 AM - 8:40 AM There Is Little Glory In Achieving Access But Many Adverse Consequences Result: How To Do It Safely For EVAR And Other Procedures
  Presenter(s):Scott L. Stevens, MD  
  View Abstract      
8:41 AM - 8:46 AM Mural Thrombus Formation In The Endograft After EVAR: How Does It Relate To Complications And The Need For Surveillance: When Can Surveillance Protocols Be Relaxed
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Abstract      
8:47 AM - 8:52 AM Is There A Difference In Type 2 Endoleak Incidence Or Behavior Between Different Endografts: What Is The Reason
  Presenter(s):Marc L. Schermerhorn, MD  
  View Abstract      
8:53 AM - 8:58 AM Value Of Preloaded Catheters And Wires In Fenestrated Stent-Grafts: How Do They Work And How Helpful Are They
  Presenter(s):Konstantinos P. Donas, MD  
  View Abstract      
8:59 AM - 9:04 AM How To Predict, Prevent And Treat Iliac Limb Occlusion In EVAR
  Presenter(s):Ronald M. Fairman, MD  
  View Abstract      
9:05 AM - 9:13 AM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
x
9:13 AM - 9:18 AM Value And Need For Secondary Interventions After TEVAR: What Factors Predict An Increased Likelihood Of A Secondary Intervention
  Presenter(s):Mark K. Eskandari, MD  
  View Abstract      
9:19 AM - 9:24 AM Tips And Tricks To Avoid Complications And Improve TEVAR Results: How Well Do Branched Grafts Work In The Aortic Arch
  Presenter(s):Dittmar Boeckler, MD  
  View Abstract      
9:25 AM - 9:30 AM Newer Branched Endografts And Large Proximal Scallops For Aortic Arch Lesions
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR / Nicholas J.W. Cheshire, MD  
  View Abstract      
9:31 AM - 9:36 AM Does Endovascular Or Open Surgical Treatment Of TAAAs Yield A Survival Benefit
  Presenter(s):Florian Dick, MD  
  View Abstract      
9:37 AM - 9:42 AM With TBADs Secondary Interventions To Get Improved False Lumen Exclusion Is Important: How To Do It With Stents, Plugs, Coils: When Should They Be Done
  Presenter(s):Joseph V. Lombardi, MD  
  View Abstract      
9:43 AM - 9:48 AM Thoracoabdominal Aneurysm Sac Perfusion And Motor Evoked Potentials To Decrease Spinal Cord Ischemia With BEVAR Procedures: Tips And Tricks
  Presenter(s):Piotr M. Kasprzak, MD  
  View Abstract      
9:49 AM - 9:54 AM How To Protect A Left Internal Mammary Artery Coronary Bypass In Aortic Arch Interventions
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Abstract      
9:55 AM - 10:00 AM How Durable Are Today’s TEVAR Devices: What Is The Need For Secondary Interventions To Fix Device Related Problems
  Presenter(s):Ronald M. Fairman, MD  
  View Abstract      
10:01 AM - 10:10 AM Panel Discussion
10:10 AM - 10:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: MORE THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
x
10:30 AM - 10:35 AM Endovascular Treatment Of Aortic And Branch Takayasu’s Disease: When Does It Work And When Does It Not: Based On An Asian Experience
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
10:36 AM - 10:41 AM Endovascular Treatment Of Takayasu’s Disease: What Is Its Value: Based On A 10-Year South American Experience
  Presenter(s):Arno von Ristow, MD  
  View Abstract      
10:42 AM - 10:47 AM What Cardiac Surgeons Do Not Know About Acute Type A And Type B Aortic Dissections
  Presenter(s):Firas F. Mussa, MD  
  View Abstract      
10:48 AM - 10:53 AM Value Of Hepatorenal Bypass To Facilitate Treatment Of TBADs And Complex AAAs
  Presenter(s):Joseph S. Giglia, MD  
  View Abstract      
10:54 AM - 10:59 AM Retroperitoneal Access To Target Arteries: A Bailout Procedure When Prograde Branch Catheterization Does Not Work For F/B EVAR
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Abstract      
11:00 AM - 11:05 AM Treatment Of Distal Aortic Growth After TEVAR For TBADs
  Presenter(s):James H. Black III, MD  
  View Abstract      
11:06 AM - 11:14 AM Panel Discussion
11:15 AM - 11:20 AM What Is The Difference Between A Penetrating Aortic Ulcer And A Saccular Aneurysm: Why It Matters
  Presenter(s):Benjamin M. Jackson, MD  
  View Abstract      
11:21 AM - 11:26 AM Tips And Tricks For Open Repair After Failed TEVAR
  Presenter(s):Karl H. Orend, MD  
  View Abstract      
11:27 AM - 11:32 AM Open Surgical Adjuncts To Preserve Failing Infrarenal Endografts And Creative Non-Femoral Access Options
  Presenter(s):Martin R. Back, MD  
  View Abstract      
11:33 AM - 11:38 AM Chronic Aortic Aneurysms After TBADs: Incidence And Treatment Methods: Long-Term Outcomes Are Poor
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Abstract      
11:39 AM - 11:44 AM How Can Patients With An Aorto-Esophageal Fistula After TEVAR Be Salvaged
  Presenter(s):Jürg Schmidli, MD  
  View Abstract      
11:45 AM - 11:50 AM How To Identify Healthy Aorta For A Landing Zone In Endovascular Aneurysm Repairs: It May Not Always Be Possible
  Presenter(s):Matthew J. Eagleton, MD  
  View Abstract      
11:51 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: CAROTID RELATED TOPICS AND RECENT ADVANCES IN ACUTE STROKE TREATMENT
x
1:00 PM - 1:05 PM Should Patients With Chronic Renal Insufficiency Undergo CAS Or CEA
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
1:06 PM - 1:11 PM Gender Specific Outcomes For CEA And CAS: Results From The SVS Registry Show That CEA Is Better In Both Men And Women
  Presenter(s):Joseph J. Ricotta II, MD, MS  
  View Abstract      
1:12 PM - 1:17 PM CAS Is Still Not As Cost Effective As CEA: But That May Change
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Abstract      
1:18 PM - 1:23 PM With Symptomatic Carotid Stenosis Are The Results Of NASCET And ECST Obsolete In View Of Advances In Medical Therapy
  Presenter(s):Alison Halliday, MS, FRCS  
  View Abstract      
1:24 PM - 1:29 PM Which Asymptomatic Carotid Stenosis Patients Should Currently Be On Statins And Medical Therapy And Which Should Get This Treatment Plus CEA Or CAS: When Will We Know For Sure And What Should We Do Now
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
1:30 PM - 1:35 PM How Common Are Carotid Stent Fractures After CAS And What Is Their Clinical Significance
  Presenter(s):Richard J. Powell, MD  
  View Abstract      
1:36 PM - 1:42 PM Panel Discussion
RECENT PROGRESS IN ACUTE STROKE TREATMENT
Moderator(s): Klaus D. Mathias, MD / Mayank Goyal, MD, FRCPC  
1:42 PM - 1:47 PM Recent Improvements In Acute Stroke Management: Impact Of New Clot Aspiration Techniques And Stent-Clot Retrievers
  Presenter(s):Stefan Mueller-Hülsbeck, MD  
  View Abstract      
1:48 PM - 1:53 PM New Developments In Acute Stroke Endovascular Treatment: Value Of Stent-Clot Retriever Systems (Solitaire From Covidien) Coupled With Balloon Guide Catheters To Decrease Forward Arterial Flow
  Presenter(s):L. Nelson Hopkins, MD  
  View Abstract      
1:54 PM - 1:59 PM New Developments In Acute Stroke Management And Endovascular Devices For Clot Removal And Managing Acute Carotid Occlusions: Success And Adverse Event Rates
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
2:00 PM - 2:11 PM Panel Discussion
END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: MORE CAROTID RELATED TOPICS
x
2:11 PM - 2:16 PM Inefficient Distal Embolic Filters A Cause Of Stroke With CAS: What Can Be Done To Offset This
  Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA  
  View Abstract      
2:17 PM - 2:22 PM How To Make CAS In Recently Symptomatic Carotid Stenosis Patients Safe: When Can CAS Compete With CEA In Such Patients
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
  View Abstract      
2:23 PM - 2:28 PM CEA Under Local Anesthesia: Was The GALA Trial Misleading: How Can This Lower Costs In The ACA Era
  Presenter(s):Dipankar Mukherjee, MD  
  View Abstract      
2:29 PM - 2:34 PM How To Improve The Results Of Early CEA For Stroke
  Presenter(s):R. Clement Darling III, MD  
  View Abstract      
2:35 PM - 2:40 PM How To Perform CAS Safely In Patients With A Non-Circumferential Severely Calcified Carotid Stenosis
  Presenter(s):Gioachino Coppi, MD  
  View Abstract      
2:41 PM - 2:46 PM The Game Is Finally Changing With Carotid Disease: When And How to Intervene Beyond Good Medical Therapy
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
  View Abstract      
2:47 PM - 2:52 PM Tips And Tricks For Performing CAS With Difficult Arch Anatomy
  Presenter(s):Enrico M. Marone, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Abstract      
2:53 PM - 2:58 PM CEA In Women: Still Searching For Parity In Access To Treatment: Why Does This Occur And What Is Its Impact
  Presenter(s):Cynthia K. Shortell, MD  
  View Abstract      
2:59 PM - 3:04 PM Which Specialty Gets The Best Outcomes With CEA; With CAS
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
3:05 PM - 3:10 PM Clinical Volume Correlates With Outcomes For CAS: It Is Undeniable
  Presenter(s):Carlos H. Timaran, MD  
  View Abstract      
3:11 PM - 3:17 PM Panel Discussion
3:17 PM - 3:24 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: LOWER EXTREMITY AND MISCELLANEOUS TOPICS
x
3:24 PM - 3:29 PM Gracilis Muscle Flap To Heal Groin Wounds With Infected Vascular Grafts: How To Do It And Results
  Presenter(s):John F. Eidt, MD  
  View Abstract      
3:30 PM - 3:35 PM Significance And Interpretation Of TLR (Target Lesion Revascularization) And Why TLR And Primary Patency Measures In Clinical Trials Can Be Misleading
  Presenter(s):John R. Laird, MD  
  View Abstract      
3:36 PM - 3:41 PM Why The TASC Classification Is No Longer Valid As A Treatment Guide
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
3:42 PM - 3:47 PM Has The Increase In Lower Extremity Interventions Led To Lower Major Amputation Rates
  Presenter(s):Manju Kalra, MBBS  
  View Abstract      
3:48 PM - 3:53 PM Tips And Tricks For OCT Guided Crossing Of Difficult SFA And Popliteal CTOs: A Way To Decrease Radiation Exposure
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Abstract      
3:54 PM - 3:59 PM Value And Limitations Of Subintimal PTA Of Aortic And Iliac Occlusive Lesions: Tips And Tricks
  Presenter(s):George H. Meier III, MD  
  View Abstract      
4:00 PM - 4:05 PM Optimal Strategies For Dealing With Heavily Calcified SFA Lesions
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
4:06 PM - 4:11 PM Endovascular Treatment Of Arterial Complications Of Pancreatitis: Tips And Tricks
  Presenter(s):Maria Antonella Ruffino, MD  
  View Abstract      
4:12 PM - 4:17 PM Importance Of Distal Embolization After SFA Interventions And How To Prevent And Treat It
  Presenter(s):Nicholas J. Morrissey, MD  
  View Abstract      
4:18 PM - 4:23 PM Hybrid Procedures In The Lower Extremity: Are They Effective And Which Are The Factors That Determine Durability
  Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS  
  View Abstract      
4:24 PM - 4:31 PM Panel Discussion
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: MORE LOWER EXTREMITY AND MISCELLANEOUS TOPICS
x
4:31 PM - 4:36 PM Do Anti-MRSA Agents Prophylactically Prevent Groin Infection After Vascular Procedures: A RCT: What Regimen Should We Use
  Presenter(s):Patrick A. Stone, MD  
  View Abstract      
4:37 PM - 4:42 PM Key Technical Tips For Preventing Groin Incision Infections And Decreasing Readmissions And Hospital Costs
  Presenter(s):Peter Henke, MD  
  View Abstract      
4:43 PM - 4:48 PM In Hemodialysis Diabetic Patients With CLI And Gangrene: When Is A Primary Amputation The Right Treatment Option And When Should Revascularization Be Attempted
  Presenter(s):Mark G. Davies, MD  
  View Abstract      
4:49 PM - 4:54 PM How IVUS Can Be Helpful In Treating Lower Extremity Ischemia And The Lesions Causing It
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Abstract      
4:55 PM - 5:00 PM A Special New Technique For Spinal Artery Mapping To Aid In Preservation Of Its Flow And Decrease Cord Ischemia With Thoracic Aortic Procedures
  Presenter(s):Jeffrey Indes, MD  
  View Abstract      
5:01 PM - 5:06 PM Tips And Tricks For Performing Optimal And Adequate Debridements Of Diabetic Foot Infections
  Presenter(s):Giustino Marcucci, MD  
  View Abstract      
5:07 PM - 5:12 PM How Should Lower Extremity Post PTA Dissections Be Managed And Why Do “Bail Out Stenting” Rates Vary So Much
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
5:13 PM - 5:18 PM Tips And Tricks To Make CFA Stenting Successful: When Is It Indicated
  Presenter(s):George H. Meier III, MD  
  View Abstract      
5:19 PM - 5:24 PM Tips And Tricks To Make A Radial Artery Approach Applicable To Most Endovascular Interventions
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Abstract      
5:25 PM - 5:30 PM Spiral Flow Prosthetic Grafts In Lower Extremity Bypasses: 1-Year Results And Beyond
  Presenter(s):Nick J. Shaper, FRCS  
  View Abstract      
5:31 PM - 5:36 PM Results And Cost Effectiveness Of Carbon Dioxide As Contrast Media For Revascularization Of TAXD A And B Femoro-Popliteal Lesions: A Prospective RCT
  Presenter(s):Mariana Krutman, MD  
  View Abstract      
5:37 PM - 5:43 PM Duplex Guided Angioplasty And Stenting vs. Conventional Endovascular Technique In Femoro-Popliteal Occlusive Disease: Comparative Results
  Presenter(s):Eduardo F. Rocha, MD  
  View Abstract      
5:43 PM - 5:53 PM Panel Discussion

End of Program K
END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: MORE STRATEGIC METHODS TO DEAL WITH SAPHENOUS INCOMPETENCE AND VARICOSE VEINS
x
6:49 AM - 6:54 AM RCT Comparing Open Surgery, Radiofrequency, Laser Or Foam Sclerotherapy For Varicose Veins
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Abstract      
6:55 AM - 7:00 AM Why Is The SVS-VQI Venous Registry Critical
  Presenter(s):Thomas W. Wakefield, MD  
  View Abstract      
7:01 AM - 7:06 AM Thermal Ablation On Anticoagulated Patients: Is It Durable And Effective
  Presenter(s):Glenn Jacobowitz, MD  
  View Abstract      
7:07 AM - 7:12 AM When LEED Isn’t Enough: The Distribution Of Thermal Energy In The Vein Wall After Endovenous Thermal Ablation
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Abstract      
7:13 AM - 7:18 AM Investigating The Effects Of Sclerotherapy And MOCA With Histology And Immunocytochemistry
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Abstract      
7:19 AM - 7:24 AM Extreme C6 Cases And Endovenous Solutions
  Presenter(s):Ignacio Escotto, MD  
  View Abstract      
7:25 AM - 7:30 AM Do The Economic Benefits Of Earlier Surgery Trump The Current Conservative Non-Operative Approach To The Healing Of Venous Ulcers
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Abstract      
7:31 AM - 7:36 AM Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation
  Presenter(s):Edward G. Mackay, MD  
  View Abstract      
7:37 AM - 7:42 AM Partial Crossectomy With Branch Preservation And Venoplasty Of Saphenous Bulb
  Presenter(s):Gioachino Coppi, MD  
7:43 AM - 7:48 AM Use Of Mechanical Chemical Ablation In Non Saphenous Veins
  Presenter(s):Julianne Stoughton, MD, FACS  
  View Abstract      
7:49 AM - 7:54 AM Step By Step Use Of Cyanoacrylate For Saphenous Ablation
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
7:55 AM - 8:00 AM Neurological Complications Of Sclerotherapy For Varicose Veins
  Presenter(s):Edward G. Mackay, MD  
  View Abstract      
8:01 AM - 8:06 AM Radiofrequency Treatment Of Perforating Veins For Recalcitrant Venous Ulcers: How To Do It And Does It Help
  Presenter(s):Peter F. Lawrence, MD  
  View Abstract      
8:07 AM - 8:12 AM Superficial Vein Thrombophlebitis: To Treat Or Not To Treat
  Presenter(s):Joseph D. Raffetto, MD  
  View Abstract      
8:13 AM - 8:18 AM Saphenous Ablation Of Complex Anatomy: Tips And Tricks
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
8:19 AM - 8:24 AM The Role Of Truncal Ablation In Venous Ulceration: Is Timing Key
  Presenter(s):Manj S. Gohel, MD, FRCS  
  View Abstract      
8:25 AM - 8:30 AM Panel Discussion
END OF SESSION 90
 
SESSION 91 SCHEDULE
Friday
SESSION 91: MORE STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION
x
8:31 AM - 8:36 AM Surgical Reconstruction Of The Deep Veins
  Presenter(s):Stephen A. Black
, MD  
  View Abstract      
8:37 AM - 8:42 AM Neo-Valve Reconstruction In The Post-Thrombotic Syndrome
  Presenter(s):Marzia Lugli, MD  
8:43 AM - 8:48 AM What Is Worse: Obstruction Or Reflux?
  Presenter(s):Mark H. Meissner, MD  
  View Abstract      
8:55 AM - 9:00 AM What Comprises The Chronic Venous Obstruction Of Post -Thrombotic Syndrome?
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
9:01 AM - 9:06 AM Reduction Internal Valvuloplasty (RIVAL) - A New Technique For Deep Vein Valve Reconstruction: Early Results
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
9:07 AM - 9:12 AM Panel Discussion
END OF SESSION 91
 
SESSION 92 SCHEDULE
Friday
SESSION 92: OTHER MISCELLANEOUS VENOUS CONDITIONS
x
9:13 AM - 9:18 AM Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Abstract      
9:19 AM - 9:24 AM Anomalous Features Of Iliac Vein Stenosis That Impact Diagnosis And Treatment
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
9:25 AM - 9:30 AM Quality Of Life Assessment After Iliac Vein Stenting For DVT From May-Thurner Syndrome
  Presenter(s):Todd Berland, MD  
  View Abstract      
9:31 AM - 9:36 AM Optimal Management Of Isolated Gastrocnemius Or Soleal Vein Thrombosis (ISGVT)
  Presenter(s):Clifford M. Sales, MD, MBA  
  View Abstract      
9:37 AM - 9:42 AM Non-Venous Vascular Complications Of Pregnancy
  Presenter(s):Joann Lohr, MD  
  View Abstract      
9:43 AM - 9:48 AM Knowns And Unknowns About Popliteal Venous Aneurysms
  Presenter(s):Ido Weinberg, MD, MSc  
  View Abstract      
9:49 AM - 9:54 AM What Is Short-Stretch Compression And Why Is That Important For Vascular Surgeons?
  Presenter(s):Joseph A. Caprini, MD  
  View Abstract      
9:55 AM - 10:00 AM Lymphedema In Cancer Patients Is Usually Due To Venous Obstructions And Therefore Treatable
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Abstract      
10:01 AM - 10:06 AM PAVA – More Understanding Of Peri-Adventitial Venous Abnormalities
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Abstract      
10:07 AM - 10:12 AM Venous Embryology
  Presenter(s):Jean Francois Uhl, MD, FACPh  
  View Abstract      
10:13 AM - 10:18 AM RCT Demonstrating The Efficacy And Benefits Of Sulodexide Treatment In Patients With Venous Ulcers
  Presenter(s):Joseph D. Raffetto, MD  
  View Abstract      
10:19 AM - 10:24 AM AVM And VM Are As Different As Apple And Orange
  Presenter(s):Byung-Boong Lee, MD  
  View Abstract      
10:25 AM - 10:30 AM Is There A Role For Percutaneous Suture Mediated Closure Systems In Venous Interventions: Tips And Tricks
  Presenter(s):Brian G. DeRubertis, MD  
  View Abstract      
10:31 AM - 10:36 AM Update On Caprini DVT Risk Assessment Score
  Presenter(s):Joseph A. Caprini, MD  
  View Abstract      
10:37 AM - 10:42 AM How To Properly Design And Interpret Clinical Trials
  Presenter(s):Thomas W. Wakefield, MD  
  View Abstract      
10:43 AM - 10:48 AM Panel Discussion
END OF SESSION 92
 
SESSION 93 SCHEDULE
Friday
SESSION 93: PELVIC INCOMPETENCE AND ITS CONSEQUENCES
x
10:49 AM - 10:54 AM Diagnosis And Treatment Paradigm For Patients With Pelvic Venous Congestion Syndrome
  Presenter(s):Melvin Rosenblatt, MD  
  View Abstract      
10:55 AM - 11:00 AM Pelvic Congestion Syndrome: Current Principles Of Diagnostic Duplex Imaging
  Presenter(s):Melvin Rosenblatt, MD  
  View Abstract      
11:01 AM - 11:06 AM Pelvic Congestion Syndrome: Current Principles Of Diagnostic Cross-Sectional Imaging
  Presenter(s):Barry Stein, MD, FSIR, FACR  
  View Abstract      
11:07 AM - 11:12 AM Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein?
  Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS  
  View Abstract      
11:13 AM - 11:18 AM Embolization Has A Major Role In The Treatment Of Varicocele And Pelvic Congestion Syndrome
  Presenter(s):Lindsay Machan, MD  
  View Abstract      
11:19 AM - 11:24 AM Pelvic Vein Reflux – Are Hemorrhoids The Next Target?
  Presenter(s):Mark S. Whiteley, MS, FRCS  
11:25 AM - 11:30 AM The Safety Of Coil Embolization Of Pelvic Veins And Subsequent Pregnancy
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Abstract      
11:31 AM - 11:36 AM Ovarian Vein, Hypogastric Vein Incompetence Or Compression Syndrome: Coil, Stent, Both, Neither?
  Presenter(s):Constantino Pena, MD  
  View Abstract      
11:37 AM - 11:42 AM Left Renal Vein Stenting Pitfalls
  Presenter(s):Constantino Pena, MD  
  View Abstract      
11:43 AM - 11:48 AM How To Treat Vulvar Veins Before Or After Pelvic Embolization
  Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS  
  View Abstract      
11:49 AM - 11:54 AM Acute Or Chronic Ovarian Vein Thrombosis: What To Do?
  Presenter(s):Mikel Sadek, MD  
  View Abstract      
11:55 AM - 12:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 93
 
SESSION 94 SCHEDULE
Friday
SESSION 94: MORE STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO-SUBCLAVIAN SYSTEM
x
1:00 PM - 1:05 PM Endovascular Management Of Ilio-Femoral DVT With Percutaneous Thrombectomy And Thrombolysis: Indications, Techniques And Results
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Abstract      
1:06 PM - 1:11 PM Pharmacomechanical Thrombolysis Of Large Volume (Extensive) DVT Using The Rapid Lysis Technique Minimizing The Need For Catheter Directed Lysis
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
1:12 PM - 1:17 PM Methods Of Aging Of Deep Vein Thrombosis
  Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
1:18 PM - 1:23 PM Rheolytic Thrombectomy For Deep Vein Thrombosis: Final Report Of A Prospective Multi-Center Registry
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Abstract      
1:24 PM - 1:29 PM Appropriate Use Of D-Dimer Testing Can Minimize Over-Utilization Of Venous Duplex Ultrasound In A Contemporary High-Volume Hospital
  Presenter(s):Albeir Y. Mousa, MD  
  View Abstract      
1:30 PM - 1:35 PM Portal Vein Thrombosis: Techniques For Treating And Recanalizing
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
1:36 PM - 1:41 PM What’s New In Thoracic Outlet Syndrome Treatment And Reporting Standards: When If Ever Should Neurologic TOS Be Treated?
  Presenter(s):Karl A. Illig, MD  
  View Abstract      
1:42 PM - 1:48 PM DEBATE: Warfarin Is Still The Treatment Of Choice For VTE: The Noacs Are Not Ready For Prime Time
  Presenter(s):Joseph A. Caprini, MD  
  View Abstract      
1:49 PM - 1:54 PM DEBATE: Warfarin Is NOT Still The Treatment Of Choice For VTE: The Noacs Are Ready For Prime Time
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
1:55 PM - 2:00 PM The Value Of Non-Invasive Diagnosis Of Venous Obstruction At The Thoracic Outlet
  Presenter(s):Enrique Criado, MD, FACS  
  View Abstract      
2:01 PM - 2:06 PM Incidence Of Upper Extremity DVT After Central Venous Catheterization And What To Do About It
  Presenter(s):Gregory L. Moneta, MD  
  View Abstract      
2:07 PM - 2:12 PM Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting?
  Presenter(s):Enrique Criado, MD, FACS  
  View Abstract      
2:13 PM - 2:18 PM Panel Discussion
END OF SESSION 94
 
SESSION 95 SCHEDULE
Friday
SESSION 95: ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS
x
2:19 PM - 2:24 PM IVC Replacement For Malignancy: How To Do It And What Is The Best Graft
  Presenter(s):Thomas C. Bower, MD  
  View Abstract      
2:25 PM - 2:30 PM Endovascular Reconstruction Techniques For Chronic IVC Occlusions
  Presenter(s):Mark J. Garcia, MD  
  View Abstract      
2:31 PM - 2:36 PM Role Of Z-Stent In Iliocaval And Caval Stenting
  Presenter(s):Seshadri Raju, MD  
  View Abstract      
2:37 PM - 2:42 PM IVC Agenesis: Is This A Real Entity
  Presenter(s):David M. Williams, MD  
  View Abstract      
2:43 PM - 2:48 PM Management Of Tumor Thrombus From Renal Cell Carcinoma Extending Into Supra Hepatic IVC And Right Heart
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
2:49 PM - 2:54 PM Patient Selection For In-Line Caval Reconstruction
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Abstract      
2:55 PM - 3:00 PM Exposure And Techniques For In-Line Caval Reconstruction
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Abstract      
3:01 PM - 3:06 PM Conduit Choices For In-Line Caval Reconstruction
  Presenter(s):Peter Gloviczki, MD  
  View Abstract      
3:07 PM - 3:12 PM Caval Tumors
  Presenter(s):William A. Marston, MD  
  View Abstract      
3:13 PM - 3:18 PM Catheter-Based Interventions For Caval Thrombosis: Which Is The Best
  Presenter(s):Iris Baumgartner, MD  
  View Abstract      
3:19 PM - 3:24 PM Panel Discussion
END OF SESSION 95
 
SESSION 96 SCHEDULE
Friday
SESSION 96: VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
x
VENA CAVA FILTRATION
3:25 PM - 3:30 PM IVC Filters In Acute DVT: Necessary Or Expensive Luxury?
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Abstract      
3:31 PM - 3:36 PM Update On The PRESERVE Vena Cava Filter Study
  Presenter(s):David L. Gillespie, MD  
  View Abstract      
3:37 PM - 3:42 PM Remove Tilted IVC Filters Immediately: Complications Are Inevitable
  Presenter(s):Werner Lang, MD  
  View Abstract      
3:43 PM - 3:48 PM Indications For IVC Filters – Are They Being Observed?
  Presenter(s):John E. Rectenwald, MD, MS  
  View Abstract      
3:49 PM - 3:54 PM Successful Techniques For Challenging IVC Filter Retrieval (Permanent And Temporary IVC Filters)
  Presenter(s):Paul J. Foley III, MD  
  View Abstract      
3:55 PM - 4:00 PM Why Aren’t Retrievable IVC Filters Retrieved?
  Presenter(s):Ronald L. Dalman, MD  
  View Abstract      
4:01 PM - 4:06 PM Major Complications After IVC Filter Placement And How To Avoid Them
  Presenter(s):Clifford M. Sales, MD, MBA  
  View Abstract      
4:07 PM - 4:12 PM Update On The Sentry Bioconvertible Non-Retrieval IVC Filter
  Presenter(s):David Rosenthal, MD  
  View Abstract      
4:13 PM - 4:18 PM What Evidence Is There That IVC Filters Save Lives?
  Presenter(s):Gregory L. Moneta, MD  
  View Abstract      
4:19 PM - 4:24 PM The Prepic Trial – Fact Or Fiction?
  Presenter(s):John E. Rectenwald, MD, MS  
  View Abstract      
4:25 PM - 4:30 PM Panel Discussion
MORE ON STENTS
4:31 PM - 4:36 PM First Experiences With The Veniti And Zilver Vena Stents
  Presenter(s):Stephen A. Black
, MD  
  View Abstract      
4:37 PM - 4:42 PM Nitinol Versus Wall Stents For Iliac Vein Stenting For Lower Limb Outflow Obstruction: Does It Really Matter? What Is An Ideal Venous Stent?
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
4:43 PM - 4:48 PM VIVO Venous Stent IDE Trial Design
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Abstract      
4:49 PM - 4:54 PM Pregnancy After Stenting For Ilio-Femoral DVT: Outcome And Complications
  Presenter(s):Gabriel Szendro, MD  
  View Abstract      
4:55 PM - 5:00 PM What Is The Nature Of In-Stent Stenosis After Venous Stenting?
  Presenter(s):David M. Williams, MD  
  View Abstract      
5:01 PM - 5:10 PM Panel Discussion
End of Program M

END OF SESSION 96